Profiles of Serum Bile Acids in Liver Diseases
Cholylglycine (CG) and sulfolithocholylglycine (SLCG) in fasting and postprandial serum were determined in patients with liver diseases by radioimmunoassay. In normal controls, fasting CG and SLCG were 54.67±68.66ng/100ml and 16.61 ±12.84ng/100ml respectively, while postprandial CG and SLCG were 61....
Main Authors: | Kim, Min Ja, Suh, Dong Jin |
---|---|
Format: | Online |
Language: | English |
Published: |
Korean Association of Internal Medicine
1986
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4534900/ |
Similar Items
-
Analysis of the Serum Bile Acid Composition for Differential Diagnosis in Patients with Liver Disease
by: Sugita, Tomonori, et al.
Published: (2015) -
Fatty liver diseases, bile acids, and FXR
by: Zhu, Yan, et al.
Published: (2016) -
Bile Acid Signaling in Liver Metabolism and Diseases
by: Li, Tiangang, et al.
Published: (2012) -
Serum Bile Acids in Repaired Tetralogy of Fallot: A Marker for Liver and Heart?
by: Grangl, Gernot, et al.
Published: (2015) -
Hormesis in Cholestatic Liver Disease; Preconditioning with Low Bile Acid Concentrations Protects against Bile Acid-Induced Toxicity
by: Verhaag, Esther M., et al.
Published: (2016)